Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0964 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.002 | 0.016 | 0.016 |
Trypanosoma cruzi | glucose-6-phosphate 1-dehydrogenase, putative | 0.0092 | 0.2656 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0627 | 0.0627 |
Plasmodium vivax | glucose-6-phosphate 1-dehydrogenase, putative | 0.0101 | 0.294 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0964 | 0.0964 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.002 | 0.016 | 0.0601 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0304 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.1168 | 0.1168 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0964 | 0.0964 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.1168 | 0.1168 |
Chlamydia trachomatis | glucose-6-phosphate 1-dehydrogenase | 0.0092 | 0.2656 | 0.5 |
Leishmania major | glucose-6-phosphate 1-dehydrogenase, putative | 0.0092 | 0.2656 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1168 | 0.1168 |
Schistosoma mansoni | DNA polymerase eta | 0.002 | 0.016 | 0.0601 |
Mycobacterium tuberculosis | Probable glucose-6-phosphate 1-dehydrogenase Zwf2 (G6PD) | 0.0032 | 0.0568 | 1 |
Brugia malayi | glucose-6-phosphate dehydrogenase | 0.0092 | 0.2656 | 0.2656 |
Echinococcus granulosus | dna polymerase eta | 0.002 | 0.016 | 0.016 |
Echinococcus multilocularis | dna polymerase kappa | 0.002 | 0.016 | 0.016 |
Loa Loa (eye worm) | hypothetical protein | 0.0304 | 1 | 1 |
Loa Loa (eye worm) | glucose-6-phosphate dehydrogenase | 0.0092 | 0.2656 | 0.2656 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.016 | 0.016 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.002 | 0.016 | 0.016 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0964 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.1168 | 0.1168 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0964 | 0.3628 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0101 | 0.294 | 1 |
Treponema pallidum | glucose-6-phosphate 1-dehydrogenase | 0.0092 | 0.2656 | 0.5 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.006 | 0.1547 | 0.5558 |
Trypanosoma cruzi | glucose-6-phosphate 1-dehydrogenase, putative | 0.0031 | 0.0518 | 0.1438 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.016 | 0.016 |
Echinococcus multilocularis | dna polymerase eta | 0.002 | 0.016 | 0.016 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0964 | 1 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0092 | 0.2656 | 1 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.0101 | 0.294 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0627 | 0.2363 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0964 | 0.3628 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0101 | 0.294 | 1 |
Trypanosoma cruzi | Glucose-6-phosphate dehydrogenase, putative | 0.003 | 0.0488 | 0.1315 |
Trypanosoma brucei | glucose-6-phosphate 1-dehydrogenase | 0.0092 | 0.2656 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.016 | 0.016 |
Echinococcus granulosus | glucose 6 phosphate 1 dehydrogenase | 0.0092 | 0.2656 | 0.2656 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0101 | 0.294 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0627 | 0.0627 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.002 | 0.016 | 0.016 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.002 | 0.016 | 0.0601 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.0101 | 0.294 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0304 | 1 | 1 |
Echinococcus multilocularis | glucose 6 phosphate 1 dehydrogenase | 0.0092 | 0.2656 | 0.2656 |
Echinococcus multilocularis | muscleblind protein | 0.0304 | 1 | 1 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.0101 | 0.294 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0964 | 1 |
Schistosoma mansoni | glucose-6-phosphate 1-dehydrogenase | 0.0092 | 0.2656 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0304 | 1 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.016 | 0.016 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0964 | 0.0964 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.2283 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.